Lv1
28 积分 2023-04-03 加入
A phase 2, adaptive randomized, double-blind, placebo-controlled, multicenter, 52-week study of HM15211 in patients with biopsy-confirmed non-alcoholic steatohepatitis – Study design and rationale of HM-TRIA-201 study
1天前
待确认
Hepatic encephalopathy – when lactulose and rifaximin are not working
3天前
已完结
SAT-110-Impact of rifaximin monotherapy or rifamixin plus lactulose on markers of inflammation in patients with cirrhosis and a history of hepatic encephalopathy
3天前
已完结
Efficacy and safety of fitusiran prophylaxis in people with haemophilia A or haemophilia B with inhibitors (ATLAS-INH): a multicentre, open-label, randomised phase 3 trial
3天前
已完结
FDA approves first anti-TFPI antibody for haemophilia A and B
15天前
已完结
Urticaria
22天前
已完结
Barzolvolimab Significantly Decreases Chronic Spontaneous Urticaria Disease Activity and is Well Tolerated: Top Line Results from a Phase 2 Trial
24天前
已关闭
Omalizumab chronic spontaneous urticaria
24天前
已完结
Chronic Urticaria
1个月前
已完结
Antithrombin exhibits anticoagulant effects on the emicizumab-based engineered bispecific antibody (NXT007)-mediated blood coagulation
1个月前
已完结
皖公网安备34019202002308
